Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| GlcNAc-1-phosphate uridyltransferase from Campylobacter jejuni, Recombinant | N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU), a bifunctional enzyme exclusive to prokaryotes, belongs to the family of sugar nucleotidyltransferases (SNTs). The enzyme binds GlcNAc-1-P and UTP, and catalyzes a uridyltransfer reaction to synthesize UDP-GlcNAc, an important precursor for cell-wall biosynthesis. Group: Enzymes. Synonyms: N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157. Enzyme Commission Number: EC 2.3.1.157. Purity: min 95% by SDS-PAGE. GlcNAc1-phosphate uridyltransferase. Source: E. coli. Species: Campylobacter jejuni. N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157; GlcNAc1-P Uridyltransferase. Cat No: NATE-1492. |  |
| GlcNAc1-phosphate uridyltransferase from E. coli K-12, Recombinant | N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU), a bifunctional enzyme exclusive to prokaryotes, belongs to the family of sugar nucleotidyltransferases (SNTs). The enzyme binds GlcNAc-1-P and UTP, and catalyzes a uridyltransfer reaction to synthesize UDP-GlcNAc, an important precursor for cell-wall biosynthesis. Group: Enzymes. Synonyms: N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157. Enzyme Commission Number: EC 2.3.1.157. Purity: min 95% by SDS-PAGE. GlcNAc1-phosphate uridyltransferase. Mole weight: 25 kDa. Source: E. coli. Species: E. coli K-12. N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157; GlcNAc1-P Uridyltransferase. Cat No: NATE-1482. | |
| GlcNAc-1-phosphate uridyltransferase from Human, Recombinant | N-Acetylglucosamine-1-phosphate uridyltransferase (GlmU), a bifunctional enzyme exclusive to prokaryotes, belongs to the family of sugar nucleotidyltransferases (SNTs). The enzyme binds GlcNAc-1-P and UTP, and catalyzes a uridyltransfer reaction to synthesize UDP-GlcNAc, an important precursor for cell-wall biosynthesis. Group: Enzymes. Synonyms: N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157. Enzyme Commission Number: EC 2.3.1.157. CAS No. 9023-06-7;9031-91-8. Purity: min 95% by SDS-PAGE. GlcNAc1-phosphate uridyltransferase. Source: E. coli. Species: Human. N-Acetylglucosamine-1-phosphate uridyltransferase; GlmU; EC 2.3.1.157; GlcNAc1-P Uridyltransferase. Cat No: NATE-1500. | |
| Glcnac-3s,na | Glcnac-3s,na. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N-ACETYL-D-GLUCOSAMINE-3-O-SULPHATE (NA);N-ACETYL-D-GLUCOSAMINE-3-SULFATE, SODIUM SALT;GLCNAC-3S, NA;N-acetylglucosamine 3-sulfate sodium*mixed anomer;N-acetylglucosamine 3-sulfate, sodium salt;N-Acetylglucosamine 3-sulfate Sodium Salt, Mixed anomers. Product Category: Heterocyclic Organic Compound. CAS No. 108347-95-1. Molecular formula: C8H14NNaO9S. Mole weight: 323.25. Product ID: ACM108347951. Alfa Chemistry ISO 9001:2015 Certified. |  |
| 2-glcnac fat | 2-glcnac fat. Uses: For analytical and research use. Group: Impurity standards. CAS No. 100-78-7. Molecular formula: C5H10O4. Mole weight: 134.13. Catalog: APB100787. |  |
| 3-O-phospho-polymannosyl GlcNAc-diphospho-ditrans,octacis-undecaprenol 3-phospho-methyltransferase | The enzyme is involved in the biosynthesis of the polymannose O-polysaccharide in the outer leaflet of the membrane of Escherichia coli serotype O9a. O-Polysaccharide structures vary extensively because of differences in the number and type of sugars in the repeat unit. The dual kinase/methylase WbdD also catalyses the preceding phosphorylation of α-D-Man-(1?2)-α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)-[α-D-Man-(1?2)-α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)]n-α-D-Man-(1?3)-α-D-Man-(1?3)-α-D-GlcNAc-diphospho-ditrans,octacis-undecaprenol (cf. EC 2.7.1.181, α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)-α-D-Man-diphospho-ditrans,octacis-undecaprenol 3-kinase). Group: Enzymes. Synonyms: WbdD. Enzyme Commission Number: EC 2.1.1.294. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-1901; 3-O-phospho-polymannosyl GlcNAc-diphospho-ditrans,octacis-undecaprenol 3-phospho-methyltransferase; EC 2.1.1.294; WbdD. Cat No: EXWM-1901. | |
| alpha-GlcNAc-Bu-COOH | Alpha-GlcNAc-Bu-COOH, a carbohydrate molecule of immense significance in the biomedicine industry, is actively employed for investigating the crucial role played by carbohydrate-protein interactions in diseases as grave as cancer, inflammatory ailments, and bacterial infections. Additionally, it plays a vital role in synthesizing glycopeptides and glycoproteins, paving the way for further insights into this promising avenue of research. Molecular formula: C13H23NO8. Mole weight: 321.32. |  |
| beta-GlcNAc-N3 | beta-GlcNAc-N3, a remarkable biomedicine, emerges as a groundbreaking solution for a myriad of diseases. Revered as a modified variant of N-acetylglucosamine, this compound assumes a paramount status as a metabolic precursor, fueling the intricate biosynthesis of glycosaminoglycans. Remarkably, the multifaceted properties of beta-GlcNAc-N3 extend beyond the realm of mere treatment. Evidencing its immense potential, it serves as a potent mitigation strategy against inflammation, while simultaneously fostering tissue regeneration. Molecular formula: C10H18N4O6. Mole weight: 290.27. | |
| beta-GlcNAc-TEG-Alkyne | beta-GlcNAc-TEG-Alkyne is a cutting-edge biomedical compound, incorporating a triethylene glycol (TEG) spacer, playing a pivotal role in the researchs for diverse ailments. Being an alkynylated derivative of beta-GlcNAc, this compound unveils invaluable insights into protein glycosylation and its intricate participation in cellular mechanisms. Molecular formula: C17H29NO9. Mole weight: 391.41. | |
| beta-GlcNAc-TEG-COOH | beta-GlcNAc-TEG-COOH is an indispensable constituent in the vibrant biomedical arena, designed to facilitate the amalgamation of curative drugs assiduously designed to counteract inflammatory cascades, autoimmunity as well as pathogenic invasions. Molecular formula: C17H31NO11. Mole weight: 425.53. | |
| beta-GlcNAc-TEG-N3 | beta-GlcNAc-TEG-N3 is an essential compound in the biomedical sphere assuming a pivotal role in the research of glycosylated biomolecules. Pertinently employed as a versatile recompound, it facilitates the incorporation of N-azidoacetylglucosamine (GlcNAc) moieties into diverse compound candidates, aimed at studying diseases encompassing cancer, inflammation and infectious disorders. Molecular formula: C14H26N4O8. Mole weight: 378.73. | |
| dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichol α-1,3-glucosyltransferase | The successive addition of three glucose residues by EC 2.4.1.267 (dolichyl-P-Glc:Man9GlcNAc2-PP-dolichol α-1,3-glucosyltransferase), EC 2.4.1.265 and EC 2.4.1.256 (dolichyl-P-Glc:Glc2Man9GlcNAc2-PP-dolichol α-1,2-glucosyltransferase) represents the final stage of the lipid-linked oligosaccharide assembly. Group: Enzymes. Synonyms: ALG8; Dol-P-Glc:Glc1Man9GlcNAc2-PP-Dol α-1,3-glucosyltransferase; dolichyl β-D-glucosyl phosphate:D-Glc-α-(1?3)-D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-M. Enzyme Commission Number: EC 2.4.1.265. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2496; dolichyl-P-Glc:Glc1Man9GlcNAc2-PP-dolichol α-1,3-glucosyltransferase; EC 2.4.1.265; ALG8; Dol-P-Glc:Glc1Man9GlcNAc2-PP-Dol α-1,3-glucosyltransferase; dolichyl β-D-glucosyl phosphate:D-Glc-α-(1?3)-D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,3-glucosyltransferase. Cat No: EXWM-2496. | |
| dolichyl-P-Glc:Man9GlcNAc2-PP-dolichol α-1,3-glucosyltransferase | The successive addition of three glucose residues by EC 2.4.1.267, EC 2.4.1.265 (Dol-P-Glc:Glc1Man9GlcNAc2-PP-Dol α-1,3-glucosyltransferase) and EC 2.4.1.256 (Dol-P-Glc:Glc2Man9GlcNAc2-PP-Dol α-1,2-glucosyltransferase) represents the final stage of the lipid-linked oligosaccharide assembly. Group: Enzymes. Synonyms: ALG6; Dol-P-Glc:Man9GlcNAc2-PP-Dol α-1,3-glucosyltransferase; dolichyl β-D-glucosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α. Enzyme Commission Number: EC 2.4.1.267. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2498; dolichyl-P-Glc:Man9GlcNAc2-PP-dolichol α-1,3-glucosyltransferase; EC 2.4.1.267; ALG6; Dol-P-Glc:Man9GlcNAc2-PP-Dol α-1,3-glucosyltransferase; dolichyl β-D-glucosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,3-glucosyltransferase. Cat No: EXWM-2498. | |
| dolichyl-P-Man:Man5GlcNAc2-PP-dolichol α-1,3-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-dolichol to Man9Glc-NAc2-PP-dolichol on the lumenal side use dolichyl β-D-mannosyl phosphate. The first step of this assembly pathway on the luminal side of the endoplasmic reticulum is catalysed by ALG3. Group: Enzymes. Synonyms: Man5GlcNAc2-PP-Dol mannosyltr. Enzyme Commission Number: EC 2.4.1.258. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2488; dolichyl-P-Man:Man5GlcNAc2-PP-dolichol α-1,3-mannosyltransferase; EC 2.4.1.258; Man5GlcNAc2-PP-Dol mannosyltransferase; ALG3; dolichyl-P-Man:Man(5)GlcNAc(2)-PP-dolichyl mannosyltransferase; Not56-like protein; Alg3 α-1,3-mannosyl transferase; Dol-P-Man:Man5GlcNAc2-PP-Dol α-1,3-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,3-mannosyltransferase. Cat No: EXWM-2488. | |
| dolichyl-P-Man:Man6GlcNAc2-PP-dolichol α-1,2-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. ALG9 mannosyltransferase catalyses the addition of two different α-1,2-mannose residues - the addition of α-1,2-mannose to Man6GlcNAc2-PP-Dol (EC 2.4.1.259) and the addition of α-1,2-mannose to Man8GlcNAc2-PP-Dol (EC 2.4.1.261). G...Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2489; dolichyl-P-Man:Man6GlcNAc2-PP-dolichol α-1,2-mannosyltransferase; EC 2.4.1.259; ALG9; ALG9 α1,2 mannosyltransferase; dolichylphosphomannose-dependent ALG9 mannosyltransferase; ALG9 mannosyltransferase; Dol-P-Man:Man6GlcNAc2-PP-Dol α-1,2-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?3)-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,2-mannosyltransferase. Cat No: EXWM-2489. | |
| dolichyl-P-Man:Man7GlcNAc2-PP-dolichol α-1,6-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. Group: Enzymes. Synonyms: ALG12; ALG12 mannosyltransferase; ALG12 α1,6mannosyltransferase. Enzyme Commission Number: EC 2.4.1.260. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2491; dolichyl-P-Man:Man7GlcNAc2-PP-dolichol α-1,6-mannosyltransferase; EC 2.4.1.260; ALG12; ALG12 mannosyltransferase; ALG12 α1,6mannosyltransferase; dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase; dolichyl-P-Man:Man7GlcNAc2-PP-dolichyl α6-mannosyltransferase; EBS4; Dol-P-Man:Man7GlcNAc2-PP-Dol α-1,6-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-1,6-mannosyltransferase. Cat No: EXWM-2491. | |
| dolichyl-P-Man:Man8GlcNAc2-PP-dolichol α-1,2-mannosyltransferase | The formation of N-glycosidic linkages of glycoproteins involves the ordered assembly of the common Glc3Man9GlcNAc2 core-oligosaccharide on the lipid carrier dolichyl diphosphate. Early mannosylation steps occur on the cytoplasmic side of the endoplasmic reticulum with GDP-Man as donor, the final reactions from Man5GlcNAc2-PP-Dol to Man9Glc-NAc2-PP-Dol on the lumenal side use dolichyl β-D-mannosyl phosphate. ALG9 mannosyltransferase catalyses the addition of two different α-1,2-mannose residues: the addition of α-1,2-mannose to Man6GlcNAc2-PP-Dol (EC 2.4.1.259) and the addition of α-1,2-mannose to Man8GlcNAc2-PP-Dol (EC 2.4.1.261). Gr... term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2492; dolichyl-P-Man:Man8GlcNAc2-PP-dolichol α-1,2-mannosyltransferase; EC 2.4.1.261; ALG9; ALG9 α1,2 mannosyltransferase; dolichylphosphomannose-dependent ALG9 mannosyltransferase; ALG9 mannosyltransferase; Dol-P-Man:Man8GlcNAc2-PP-Dol α-1,2-mannosyltransferase; dolichyl β-D-mannosyl phosphate:D-Man-α-(1?2)-D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?2)-D-Man-α-(1?3)-[D-Man-α-(1?6)]-D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol 2-α-D-mannosyltransferase. Cat No: EXWM-2492. | |
| Fmoc-Thr(ß-D-GlcNAc(Ac)3)-OH | Fmoc-Thr(GlcNAc)3(Ac) is a complex molecule that belongs to the family of Fmoc-protected amino acids. It is typically used in the synthesis of peptides and serves as an important building block. The molecule has a beta configuration of GlcNAc(Ac)3, which refers to three N-acetylated glucosamine residues, and an acetyl group attached to the beta carboxyl group of the threonine residue. Since their introduction in the 1980s, Fmoc-protected amino acids have become important in the field of peptide synthesis, and Fmoc-Thr(GlcNAc)3(Ac) is no exception. Uses: Fmoc-thr(glcnac)3(ac) has several applications in scientific experiments. it is a useful building block in the synthesis of peptide therapeutics. it can also be used in the synthesis of glycopeptides, which are peptides with one or more sugar units attached. Additional or Alternative Names: Fmoc-Thr(GlcNAc)3(Ac). Product Category: Amino Acids. CAS No. 160168-40-1. Molecular formula: C33H38N2O13. Mole weight: 670.7. Purity: Peak Area by HPLC ≥95%. IUPACName: (2S,3R)-3-[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid. Canonical SMILES: CC(C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)OC4C(C(C(C(O4)COC(=O)C)OC(=O)C)OC(=O)C)NC(=O)C. Density: 1.38±0.1g g/mL at 20 °C(lit.). Product ID: ACM160168401. Alfa Chemistry ISO 9001:2015 Certified. | |
| Galα1-3Galβ1-4GlcNAcα1-HDPE | It is a neoglycolipid synthesised by conjugating oligosaccharide via an amino group and a 3-atom linker arm to 1,2-di-O-hexadecyl-sn-glycero-3-phosphoethanolamine (HDPE). Molecular formula: C60H116N3PO22. Mole weight: 1262.73. | |
| Galβ1-4GlcNAcβ1-HDPE | It is a neoglycolipid synthesised by conjugating oligosaccharide via an amino group and a 3-atom linker arm to 1,2-di-O-hexadecyl-sn-glycero-3-phosphoethanolamine (HDPE). Molecular formula: C54H106N3PO17. Mole weight: 1100.40. | |
| GDP-Man:Man1GlcNAc2-PP-dolichol α-1,3-mannosyltransferase | The biosynthesis of asparagine-linked glycoproteins utilizes a dolichyl diphosphate-linked glycosyl donor, which is assembled by the series of membrane-bound glycosyltransferases that comprise the dolichol pathway. Alg2 mannosyltransferase from Saccharomyces cerevisiae carries out an α1,3-mannosylation of D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol, followed by an α1,6-mannosylation (cf. EC 2.4.1.257), to form the first branched pentasaccharide intermediate of the dolichol pathway. Group: Enzymes. Synonyms: Alg2 mannosyltransferase (ambiguous); ALG2 (gene name, ambiguous); glycolipid 3-α-mannosyltransferase; GDP-mannose:glycolipid 3-&alph. Enzyme Commission Number: EC 2.4.1.132. CAS No. 81181-76-2. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2357; GDP-Man:Man1GlcNAc2-PP-dolichol α-1,3-mannosyltransferase; EC 2.4.1.132; 81181-76-2; Alg2 mannosyltransferase (ambiguous); ALG2 (gene name, ambiguous); glycolipid 3-α-mannosyltransferase; GDP-mannose:glycolipid 3-α-D-mannosyltransferase; GDP-Man:Man1GlcNAc2-PP-Dol α-1,3-mannosyltransferase; GDP-D-mannose:D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol 3-α-mannosyltransferase. Cat No: EXWM-2357. | |
| GDP-Man:Man2GlcNAc2-PP-dolichol α-1,6-mannosyltransferase | The biosynthesis of asparagine-linked glycoproteins utilizes a dolichyl diphosphate-linked glycosyl donor, which is assembled by the series of membrane-bound glycosyltransferases that comprise the dolichol pathway. Alg2 mannosyltransferase from Saccharomyces cerevisiae carries out an α1,3-mannosylation (cf. EC 2.4.1.132) of β-D-Man-(1?4)-β-D-GlcNAc-(1?4)-α-D-GlcNAc-diphosphodolichol, followed by an α1,6-mannosylation, to form the first branched pentasaccharide intermediate of the dolichol pathway. Group: Enzymes. Synonyms: GDP-Man:Man2GlcNAc2-PP-Dol α-1,6-mannosyltransferase; Alg2 mannosyltransferase (ambiguous); ALG2 (gene name, ambiguous); GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransfera. Enzyme Commission Number: EC 2.4.1.257. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2487; GDP-Man:Man2GlcNAc2-PP-dolichol α-1,6-mannosyltransferase; EC 2.4.1.257; GDP-Man:Man2GlcNAc2-PP-Dol α-1,6-mannosyltransferase; Alg2 mannosyltransferase (ambiguous); ALG2 (gene name, ambiguous); GDP-Man:Man1GlcNAc2-PP-dolichol mannosyltransferase (ambiguous); GDP-D-mannose:D-Man-α-(1?3)-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol α-6-mannosyltransferase. Cat No: EXWM-2487. | |
| GDP-Man:Man3GlcNAc2-PP-dolichol α-1,2-mannosyltransferase | The biosynthesis of asparagine-linked glycoproteins (N-linked protein glycosylation) utilizes a dolichyl diphosphate-linked glycosyl donor, which is assembled by the series of membrane-bound glycosyltransferases that comprise the dolichol pathway. ALG11 mannosyltransferase from Saccharomyces cerevisiae carries out two sequential steps in the formation of the lipid-linked core oligosaccharide, adding two mannose residues in α(1?2) linkages to the nascent oligosaccharide. Group: Enzymes. Synonyms: ALG11; AL. Enzyme Commission Number: EC 2.4.1.131. CAS No. 74506-43-7. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2356; GDP-Man:Man3GlcNAc2-PP-dolichol α-1,2-mannosyltransferase; EC 2.4.1.131; 74506-43-7; ALG11; ALG11 mannosyltransferase; LEW3 (gene name); At2G40190 (gene name); gmd3 (gene name); galactomannan deficiency protein 3; GDP-mannose:glycolipid 1,2-α-D-mannosyltransferase; glycolipid 2-α-mannosyltransferase; GDP-mannose:glycolipid 2-α-D-mannosyltransferase; GDP-Man:Man3GlcNAc2-PP-Dol α-1,2-mannosyltransferase; GDP-α-D-mannose:D-Man-α-(1?3)-[D-Man-α-(1?6)]-D-Man-β-(1?4)-D-GlcNAc-β-(1?4)-D-GlcNAc-diphosphodolichol 2-α-D-mannosyltransferase. Cat No: EXWM-2356. | |
| GlcA[3S]b(1-3)Galb(1-4)GlcNAcb(1-2)Mana-Ethylazide | GlcA[3S]b(1-3)Galb(1-4)GlcNAcb(1-2)Mana-Ethylazide is an innovative biomedical product, showcasing remarkable anti-inflammatory and anti-fibrotic effects. Molecular formula: C28H44N4Na20O25S. Mole weight: 1328.52. | |
| Hybrid with bisecting GlcNAc | Hybrid with bisecting GlcNAc embodies a quintessential carbohydrate, meticulously orchestrated to become a pivotal mover in the contemporary regulation of tumor progression. With finesse and precision, it tweaks the glycosylation patterns, effectively curtailing the growth of numerous cancer cell types, whilst simultaneously inducing apoptosis. Moreover, its therapeutic potential extends to a panacea for the inexorable toll of Alzheimer's and Parkinson's disease. Synonyms: GlcNAcβ 1-4[Manα 1-6(Manα 1-3)Manα 1-6][GlcNAcβ 1-2Manα 1-3]Manβ 1-4GlcNAcβ 1-4GlcNAc. Molecular formula: C62H104N4O46. Mole weight: 1641.49. | |
| L-Fucα1-6GlcNAc | L-Fucα1-6GlcNAc, a carbohydrate molecule with intricate connections to glycobiology and biomedicine, is fundamental to complex mechanisms like cell-to-cell communication, inflammation, and cancer metastasis. It is a key point of interest for the potential treatment of autoimmune diseases such as multiple sclerosis and as a biomarker for cancer diagnosis and progress tracking. The distinctive configuration and biological operations of L-Fucα1-6GlcNAc present an excellent opportunity for drug development and diagnostic applications. Molecular formula: C14H25NO10. Mole weight: 367.35. | |
| Lys-Trp-Lys-(Ser(GlcNAc-β-D)400)-Tau Peptide (388-411)-Lys-Lys(biotinyl) amide | Synonyms: H-Lys-Trp-Lys-His-Gly-Ala-Glu-Ile-Val-Tyr-Lys-Ser-Pro-Val-Val-Ser(GlcNAc-β-D)-Gly-Asp-Thr-Ser-Pro-Arg-His-Leu-Ser-Asn-Val-Lys-Lys(biotinyl)-NH2. Grades: ≥95%. CAS No. 2022974-40-7. Molecular formula: C164H263N47O47S. Mole weight: 3677.25. | |
| Man5GlcNAc | Man5GlcNAc is a quintessential molecule assuming a pivotal function in the realm of drug discovery aimed at studying glycosylation-related maladies including cancer, diabetes and hereditary anomalies. Its distinctive configuration bestows profound insights into protein folding, cellular signaling and pathogenic mechanisms, thereby rendering it an invaluable compound for the investigation and advancement of researchs. Synonyms: Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-3)]Man(b1-4)GlcNAc. CAS No. 74385-50-5. Molecular formula: C38H65NO31. Mole weight: 1031.91. | |
| Man6GlcNAc (I) | Man6GlcNAc (I) as an indispensable intermediate in the intricate biosynthesis of complex N-glycans. It intricately participates in a myriad of vital biological processes, encompassing cellular recognition, signal transduction and immune response. Furthermore, this compound stands as a cherished compound in the research and development of glycosylation-related diseases and congenital disorders of glycosylation. Synonyms: Man(a1-6)[Man(a1-3)]Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc. CAS No. 70158-31-5. Molecular formula: C44H75NO36. Mole weight: 1194.05. | |
| Man6GlcNAc(II) | Man6GlcNAc(II) is an indispensable glycan moiety identified on N-glycoproteins assuming a pivotal function in protein folding, trafficking and quality control mechanisms within a biological framework. It unequivocally serves as an obligatory constituent for a diverse array of enzymes instrumental in glycosylation processes. In biomedical research, Man6GlcNAc(II) finds application in elucidating regulatory mechanisms of glycoproteins, exploring therapeutic modalities for lysosomal storage disorders and deciphering ailments stemming from irregular protein glycosylation. Synonyms: Man(a1-2)Man(a1-3)Man(a1-6)[Man(a1-2)Man(a1-3)]Man(b1-4)GlcNAc. Molecular formula: C44H75NO36. Mole weight: 1194.05. | |
| Neu5Ac(a2-6)Gal(b1-3)GlcNAc-b-pNP | Neu5Ac(a2-6)Gal(b1-3)GlcNAc-b-pNP is an exquisite glycosaminoglycan derivative, serving as an exemplary substrate in enzymatic assays. Its prevalent utilization lies in the elucidation of sialyltransferase activity within the realm of glycosylation phenomena. Remarkably mimicking select cell surface carbohydrates, this compound facilitates profound comprehension of glycan-mediated interplay, encompassing receptor-ligand discernment and the intricate dynamics of pathogen-host affiliation. Synonyms: Neu5Ac(a2-6)Gal(b1-4)GalNAc-b-4-nitrophenol. Molecular formula: C31H45N3O21. Mole weight: 795.70. | |
| Neu5ac alpha(2-6)gal beta(1-4)glcnac-beta-pnp | Neu5ac alpha(2-6)gal beta(1-4)glcnac-beta-pnp. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N0856, Neu5Ac alpha(2-6)Gal beta(1-4)GlcNAc-beta-pNP, 501427-93-6. Product Category: Heterocyclic Organic Compound. CAS No. 501427-93-6. Molecular formula: C31H45N3O21. Mole weight: 795.7. Purity: >97.0%(LC). IUPACName: (2R,4R,5R,6R)-5-acetamido-2-[[(2S,3R,4S,5S,6S)-6-[(2S,3S,4R,5S,6S)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-3,4,5-trihydroxyoxan-2-yl]methoxy]-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid. Canonical SMILES: CC(=O)NC1C(CC(OC1C(C(CO)O)O)(C(=O)O)OCC2C(C(C(C(O2)OC3C(OC(C(C3O)NC(=O)C)OC4=CC=C(C=C4)[N+](=O)[O-])CO)O)O)O)O. Product ID: ACM501427936. Alfa Chemistry ISO 9001:2015 Certified. | |
| N-GlcNAc-Biotin | N-GlcNAc-Biotin is a groundbreaking compound, primarily renowned for its multifaceted role as a labeling tool. It showcases unrivaled proficiency in elucidating the intricacies of protein-protein interactions and carbohydrate function. Synonyms: 2-Acetamido-N-biotinyl-2-deoxy-b-D-glucopyranosylamine; 2-Acetamido-2-deoxy-b-D-glucopyranosylaminobiotin. CAS No. 1272755-69-7. Molecular formula: C18H30N4O7S. Mole weight: 446.52. | |
| O-Linked GlcNAc transferase substrate | O-Linked GlcNAc transferase substrate is a biological active peptide. (A peptide substrate of O-linked GlcNAc transferase (OGT), a eukaryotic glycosyltransferase that uses UDP-GlcNAc as a glycosyl donor.). Uses: Scientific research. Group: Peptides. CAS No. 954381-93-2. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-P5375. |  |
| polymannosyl GlcNAc-diphospho-ditrans,octacis-undecaprenol kinase | The enzyme is involved in the biosynthesis of the polymannose O-polysaccharide in the outer leaflet of the membrane of Escherichia coli serotype O9a. O-Polysaccharide structures vary extensively because of differences in the number and type of sugars in the repeat unit. The dual kinase/methylase WbdD also catalyses the methylation of 3-phospho-α-D-Man-(1?2)-α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)-[α-D-Man-(1?2)-α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)]n-α-D-Man-(1?3)-α-D-Man-(1?3)-α-D-GlcNAc-α-diphospho-ditrans,octacis-undecaprenol (cf. EC 2.1.1.294, 3-phospho-α-D-Man-(1?2)-α-D-Man-(1?3)-α-D-Man-(1?3)-α-D-Man-diphospho-ditrans,octacis-undecaprenol 3-phospho-methyltransferase). Group: Enzymes. Synonyms: WbdD. Enzyme Commission Number: EC 2.7.1.181. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3013; polymannosyl GlcNAc-diphospho-ditrans,octacis-undecaprenol kinase; EC 2.7.1.181; WbdD. Cat No: EXWM-3013. | |
| protein O-GlcNAcase | Within higher eukaryotes post-translational modification of protein serines/threonines with N-acetylglucosamine (O-GlcNAc) is dynamic, inducible and abundant, regulating many cellular processes by interfering with protein phosphorylation. EC 2.4.1.255 (protein O-GlcNAc transferase) transfers GlcNAc onto substrate proteins and EC 3.2.1.169 (protein O-GlcNAcase) cleaves GlcNAc from the modified proteins. Group: Enzymes. Synonyms: OGA; glycoside hydrolase O-GlcNAcase; O-GlcNAcase; BtGH84; O-GlcNAc hydrolase. Enzyme Commission Number: EC 3.2.1.169. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-3851; protein O-GlcNAcase; EC 3.2.1.169; OGA; glycoside hydrolase O-GlcNAcase; O-GlcNAcase; BtGH84; O-GlcNAc hydrolase. Cat No: EXWM-3851. | |
| protein O-GlcNAc transferase | Within higher eukaryotes post-translational modification of protein serines/threonines with N-acetylglucosamine (O-GlcNAc) is dynamic, inducible and abundant, regulating many cellular processes by interfering with protein phosphorylation. EC 2.4.1.255 (protein O-GlcNAc transferase) transfers GlcNAc onto substrate proteins and EC 3.2.1.169 (protein O-GlcNAcase) cleaves GlcNAc from the modified proteins. Group: Enzymes. Synonyms: O-GlcNAc transferase; OGTase; O-linked N-acetylglucosaminyltransferase; uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase; protein O-linked β-N-acetylglucosamine transferase. Enzyme Commission Number: EC 2.4.1.255. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2485; protein O-GlcNAc transferase; EC 2.4.1.255; O-GlcNAc transferase; OGTase; O-linked N-acetylglucosaminyltransferase; uridine diphospho-N-acetylglucosamine:polypeptide β-N-acetylglucosaminyltransferase; protein O-linked β-N-acetylglucosamine transferase. Cat No: EXWM-2485. | |
| (Ser(GlcNAc-β-D)236)-EMSY (230-240) | EMSY is a binding partner of BRCA2, a breast cancer susceptibility protein involved in double-stranded DNA repair. EMSY is thought to play a role in maintaining the stability of genomics in the M-phase. Synonyms: H-Thr-Ile-Thr-Val-Pro-Val-Ser(GlcNAc-β-D)-Gly-Ser-Pro-Lys-OH; L-Lysine, L-threonyl-L-isoleucyl-L-threonyl-L-valyl-L-prolyl-L-valyl-O-[2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-L-serylglycyl-L-seryl-L-prolyl-. Grades: ≥95%. CAS No. 2243207-03-4. Molecular formula: C56H97N13O21. Mole weight: 1288.46. | |
| Tri-O-acetyl-a-D-GlcNAc-FMOC-Asn | tri-O-acetyl-GlcNAca-FMOC-Asn. Product ID: 3-02668. Molecular formula: C33H35N3O14. Mole weight: 697.29. |  |
| Tri-O-acetyl-b-D-GlcNAc-FMOC-Asn | tri-O-acetyl-GlcNAc-ß-FMOC-Asn. Product ID: 3-02678. Molecular formula: C33H35N3O14. Mole weight: 697.29. Properties: LNH. | |
| Tri-O-acetyl-b-D-GlcNAc-Fmoc Asn tert-Butyl Ester | Tri-O-acetyl-b-D-GlcNAc-Fmoc Asn tert-Butyl Ester is a valuable compound acting as a protecting tool during peptide synthesis, specifically for the amino acid asparagine (Asn). This product plays a crucial role in producing high-quality peptides by safeguarding the Asn residue from undesired side reactions. It ensures efficient peptide assembly and aids in the development of drugs targeting various diseases. Molecular formula: C34H45N3O13. Mole weight: 703.73. | |
| UDP-3-O-(R-3-hydroxymyristoyl)-GlcNAc disodium | a substrate for UDP-3-O-acyl-N-acetylglucosamine deacetylase(LpxC). Synonyms: UDP-3-O-(R-3-hydroxymyristoyl)-N-acetyl-D-glucosamine sodium. Molecular formula: C31H51N3O19P2·2Na. Mole weight: 877.67. | |
| UDP-Gal:α-D-GlcNAc-diphosphoundecaprenol β-1,3-galactosyltransferase | The enzyme is involved in the the biosynthesis of the O-polysaccharide repeating unit of Escherichia coli O7:K1 (VW187). Requires Mn2+. Group: Enzymes. Synonyms: WbbD; WbbD β3Gal-transferase; UDP-Gal:GlcNAc-R β1,3-galactosyltransferase; UDP-Gal:GlcNAcα-pyrophosphate-R β1,3-galactosyltransferase; UDP-Gal:GlcNAc-R galactosyltransferase. Enzyme Commission Number: EC 2.4.1.303. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2538; UDP-Gal:α-D-GlcNAc-diphosphoundecaprenol β-1,3-galactosyltransferase; EC 2.4.1.303; WbbD; WbbD β3Gal-transferase; UDP-Gal:GlcNAc-R β1,3-galactosyltransferase; UDP-Gal:GlcNAcα-pyrophosphate-R β1,3-galactosyltransferase; UDP-Gal:GlcNAc-R galactosyltransferase. Cat No: EXWM-2538. | |
| UDP-Gal:α-D-GlcNAc-diphosphoundecaprenol β-1,4-galactosyltransferase | The enzyme is involved in the the biosynthesis of the O-polysaccharide repeating unit of the bacterium Shigella boydii B14. The activity is stimulated by Mn2+ or to a lesser extent by Mg2+, Ca2+, Ni2+ or Pb2+. Group: Enzymes. Synonyms: WfeD; UDP-Gal:GlcNAc-R 1,4-Gal-transferase; UDP-Gal:GlcNAc-pyrophosphate-lipid β-1,4-galactosyltransferase. Enzyme Commission Number: EC 2.4.1.304. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2539; UDP-Gal:α-D-GlcNAc-diphosphoundecaprenol β-1,4-galactosyltransferase; EC 2.4.1.304; WfeD; UDP-Gal:GlcNAc-R 1,4-Gal-transferase; UDP-Gal:GlcNAc-pyrophosphate-lipid β-1,4-galactosyltransferase. Cat No: EXWM-2539. | |
| UDP-Glc:α-D-GlcNAc-glucosaminyl-diphosphoundecaprenol β-1,3-glucosyltransferase | The enzyme is involved in the the biosynthesis of the O-polysaccharide repeating unit of the bacterium Escherichia coli serotype O56 and serotype O152. Group: Enzymes. Synonyms: WfaP; WfgD; UDP-Glc:GlcNAc-pyrophosphate-lipid β-1,3-glucosyltransferase; UDP-Glc:GlcNAc-diphosphate-lipid β-1,3-glucosyltransferase. Enzyme Commission Number: EC 2.4.1.305. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2540; UDP-Glc:α-D-GlcNAc-glucosaminyl-diphosphoundecaprenol β-1,3-glucosyltransferase; EC 2.4.1.305; WfaP; WfgD; UDP-Glc:GlcNAc-pyrophosphate-lipid β-1,3-glucosyltransferase; UDP-Glc:GlcNAc-diphosphate-lipid β-1,3-glucosyltransferase. Cat No: EXWM-2540. | |
| UDP-GlcNAc.2Na | Cas No. 91183-98-1. | |
| UDP-GlcNAc 4-epimerase from Plesiomonas shigelloides O17, Recombinant | In enzymology, an UDP-N-acetylglucosamine 4-epimerase (EC 5.1.3.7) is an enzyme that catalyzes the chemical reaction: UDP-N-acetyl-D-glucosamine ? UDP-N-acetyl-D-galactosamine. Hence, this enzyme has one substrate, UDP-N-acetyl-D-glucosamine, and one product, UDP-N-acetyl-D-galactosamine. This enzyme belongs to the family of isomerases, specifically those racemases and epimerases acting on carbohydrates and derivatives. Group: Enzymes. Synonyms: UDP-N-acetyl-D-glucosamine 4-epimerase; UDP acetylglucosamine epimerase; uridine diphosphoacetylglucosamine epimerase; uridine diphosphate N-acetylglucosamine-4-epimerase; uridine 5'-diphospho-N-acetylglucosamine-4-epimerase. Enzyme Commission Number: EC 5.1.3.7. CAS No. 9024-16-2. Purity: min 95% by SDS-PAGE. UDP-GlcNAc 4-Epimerase. Mole weight: 38 kDa. Source: E. coli. Species: Plesiomonas shigelloides O17. UDP-N-acetyl-D-glucosamine 4-epimerase; UDP acetylglucosamine epimerase; uridine diphosphoacetylglucosamine epimerase; uridine diphosphate N-acetylglucosamine-4-epimerase; uridine 5'-diphospho-N-acetylglucosamine-4-epimerase; UDP-GlcNAc 4-Epimerase. Cat No: NATE-1497. | |
| UDP-GlcNAc:ribostamycin N-acetylglucosaminyltransferase | Involved in biosynthesis of the aminoglycoside antibiotic neomycin. Requires a divalent metal ion, optimally Mg2+, Mn2+ or Co2+. Group: Enzymes. Synonyms: neoK (gene name). Enzyme Commission Number: EC 2.4.1.285. Storage: Store it at +4 ?C for short term. For long term storage, store it at -20 ?C?-80 ?C. Form: Liquid or lyophilized powder. EXWM-2518; UDP-GlcNAc:ribostamycin N-acetylglucosaminyltransferase; EC 2.4.1.285; neoK (gene name). Cat No: EXWM-2518. | |
| 2,3-Di-O-acetyl-U-5-CEP | 2,3-Di-O-acetyl-U-5-CEP is a reagent used in the biosynthesis of C-glycosidic UDP-GlcNAc analogs as substrate-based inhibitors of UDP-GlcNAc 2-epimerase. Group: Biochemicals. Grades: Highly Purified. CAS No. 208655-84-9. Pack Sizes: 5mg, 10mg. Molecular Formula: C22H33N4O9P, Molecular Weight: 528.49. US Biological Life Sciences. |  Worldwide |
| 2-Acetamido-2,4-dideoxy-4-fluoro-a-D-glucopyranose | 2-Acetamido-2,4-dideoxy-4-fluoro-a-D-glucopyranose is a pivotal compound extensively utilized in the biomedical sector, demonstrating remarkable antimicrobial efficacy. It assumes a paramount position in combating select bacterial infections, thereby serving as an invaluable asset within the domain of antibiotic formulation and therapeutic agent design. Its profound impact on the mitigation of infectious diseases reinforces its indispensability in the ongoing battle against such maladies. Synonyms: 4-F-GlcNAc. CAS No. 129728-87-6. Molecular formula: C8H14FNO5. Mole weight: 223.2. | |
| 2-Acetamido-2-deoxy-3-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose | 2-Acetamido-2-deoxy-3-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose is a versatile compound extensively used in the biomedical industry as a building block for synthesizing glycosidic compounds. Its unique chemical structure provides a platform for developing therapeutic molecules targeting various diseases including cancer, inflammation, and infectious diseases. Synonyms: GlcNAc-b-1,3-GalNAc. CAS No. 95673-98-6. Molecular formula: C16H28N2O11. Mole weight: 424.4. | |
| 2-Acetamido-2-deoxy-3-O-(a-L-fucopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-3-O-(α-L-fucopyranosyl)-D-glucopyranose is a highly significant compound within the biomedical sector, employed as a facilitator in the research and development of targeted drugs and therapeutic methodologies tailored to cellular receptors and signaling pathways. Synonyms: 3-Fucosyl GlcNAc 2-(Acetylamino)-2-deoxy-3-O-(6-deoxy-a-L-galactopyranosyl)-D-glucopyranose Fuc-a-1,3-GlcNAc. CAS No. 52630-68-9. Molecular formula: C14H25NO10. Mole weight: 367.35. | |
| 2-Acetamido-2-deoxy-3-O-methyl-D-glucopyranose | 2-Acetamido-2-deoxy-3-O-methyl-D-glucopyranose is commonly known as N-acetylglucosamine mainly functioning in involving combatting bacterial infections, specifically those instigated by gram-positive bacteria. Furthermore, it fosters the formulation of therapeutic remedies to tackle ailments such as cancer and metabolic disorders. Synonyms: 2-Acetamido-2-deoxy-3-O-methyl-D-glucopyranose; NAGKi; 3-O-Methyl-N-acetyl-D-glucosamine; N-[(3R,4R,5S,6R)-2,5-DIHYDROXY-6-(HYDROXYMETHYL)-4-METHOXYOXAN-3-YL]ACETAMIDE; N-((3R,4R,5S,6R)-2,5-DIHYDROXY-6-(HYDROXYMETHYL)-4-METHOXYTETRAHYDRO-2H-PYRAN-3-YL)ACETAMIDE; 3-O-methyl-GlcNAc; NAGK i; NAGK-i; 3-o-methyl-n-acetylglucosamine; SCHEMBL11285039; DTXSID60692824; AKOS027379652; 2-(acetylamino)-2-deoxy-3-O-methyl-D-glucose; W-204117; D-GLUCOSE,2-(ACETYLAMINO)-2-DEOXY-3-O-METHYL-. CAS No. 94825-74-8. Molecular formula: C9H17NO6. Mole weight: 235.23. | |
| 2-Acetamido-2-deoxy-4-O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-4-O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-D-glucopyranose is a biomedicine compound used for the research of bacterial infections and certain types of cancers. By inhibiting essential enzymes, this product disrupts the growth and reproduction of harmful bacteria, providing an effective antibiotic action. Synonyms: LacdiNAc GalNAc-b-1-4-GlcNAc. CAS No. 136198-41-9. Molecular formula: C16H28N2O11. Mole weight: 424.40. | |
| 2-Acetamido-2-deoxy-4-O-(3-sulfo-a-D-galactopyranosyl)-3-O-(a-L-fucopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-4-O-(3-sulfo-α-D-galactopyranosyl)-3-O-(α-L-fucopyranosyl)-D-glucopyranose, a highly intricate and scientifically advanced biomedical compound, is harnessed for the therapeutic intervention of distinct ailments. Manifesting an unprecedented and unparalleled structural configuration, it exhibits immense promise in the realm of precision medicine, specifically addressing neoplastic disorders, inflammatory cascades, and infectious pathologies. Synonyms: 3-SO3H-Gal-b-1,4-(Fuc-a-1,3)GlcNAc. CAS No. 153153-62-9. Molecular formula: C20H35NO18S. Mole weight: 609.55. | |
| 2-Acetamido-2-deoxy-4-O-([4-O-b-D-galactopyranosyl]-b-D-galactopyranosyl)-D-glucopyranose | b-D-Gal1®4-b-D-Gal-1®4-D-GlcNAc. Grades: CAS No. 115114-32-4. Product ID: 3-02364. Molecular formula: C20H35NO16. Mole weight: 545.5. Purity: 0.85. Properties: LND-2. | |
| 2-Acetamido-2-deoxy-4-O-(a-D-galactopyranosyl)-D-glucopyranose | Product Description: 2-Acetamido-2-deoxy-4-O-(α-D-galactopyranosyl)-D-glucopyranose, an extensively researched compound in the biomedical industry, showcases its remarkable potential in the development of innovative therapeutic agents. Widely employed in biomedicine, this compound proves indispensable in combating bacterial and viral infections, attributing to its remarkable antimicrobial properties. Synonyms: Gal-a1-4-GlcNAc. Grades: 95%. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| 2-Acetamido-2-deoxy-4-O-(a-L-fucopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-4-O-(a-L-fucopyranosyl)-D-glucopyranose, a highly intricate and noteworthy compound, holds immense significance in the realm of biomedical research and drug development. Its multifaceted nature has engendered extensive exploration, aiming to shed light on its potential therapeutic applications against a myriad of afflictions. With its remarkable biological activities, this compound assumes a pivotal role in deciphering intricate cellular processes and forging tailored therapeutic approaches. Synonyms: Fuc-a-1,4-GlcNAc. CAS No. 76211-71-7. Molecular formula: C14H25NO10. Mole weight: 367.35. | |
| 2-Acetamido-2-deoxy-4-O-(b-D-galactofuranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-4-O-(b-D-galactofuranosyl)-D-glucopyranose is a bioactive compound prevalent in the biomedical arena, showcasing immense promise for combating a wide array of diseases, encompassing cancer and bacterial infections. Synonyms: Gal-b-1,4-GlcNAc. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| 2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-6-sulfo-D-glucopyranose sodium salt | 2-Acetamido-2-deoxy-4-O-(b-D-galactopyranosyl)-6-sulfo-D-glucopyranose sodium salt, a pivotal compound in the biomedical sector, is extensively employed in the formulation of medication and therapeutic interventions for ailments, encompassing cancer, diabetes, and inflammation. Its indispensability in the realm of biomedicine lies in its ability to augment drug potency and streamline site-specific treatment strategies, thus amplifying the importance of this product. Synonyms: N-Acetyl-D-lactosmine 6-sulfate sodium salt Galb-(1-4)-GlcNAc(6S). CAS No. 145447-78-5. Molecular formula: C14H24NO14S.Na. Mole weight: 485.39. | |
| 2-Acetamido-2-deoxy-4-O-(b-D-mannopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-4-O-(b-D-mannopyranosyl)-D-glucopyranose is a fundamental constituent in pharmacological formulations specifically formulated to alleviate bacterial infections, predominantly instigated by Gram-positive microorganisms. The inherent potency of its antimicrobial attributes deems it as an optimal contender in theresearch of against sundry maladies. Synonyms: Man-b-1,4-GlcNAc. CAS No. 55637-63-3. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| 2-Acetamido-2-deoxy-4-O-(β-D-2-acetamido-2-deoxyglucopyranosyl)-α-D-galactopyranose | Oligosaccharide widely distributed in the human digestive tract. Synonyms: 2-(Acetylamino)-4-O-[2-(acetylamino)-2-deoxy-β-D-glucopyranosyl]-2-deoxy-α-D-galactose; GlcNAc1β-4GalNAc. Molecular formula: C16H28N2O11. Mole weight: 424.4. | |
| 2-Acetamido-2-deoxy-4-O-(β-D-galactofuranosyl)-α,β-D-glucopyranose | Synthetic galactofuranose-containing oligosaccharides could be useful for the identification of strains of T. cruzi as well as for studies on the inhibition of the biosynthesis of these unique O-linked chains. Synonyms: Galf1-β-4-GlcNAc. Grades: 98%. Molecular formula: C14H25NO11. Mole weight: 383.23. | |
| 2-Acetamido-2-deoxy-5-thio-D-glucose | 2-Acetamido-2-deoxy-5-thio-D-glucose is a vital compound heavily used in the biomedical industry. This product plays a crucial role in the research and development of pharmaceutical drugs targeting bacterial and fungal infections. It acts by hindering the growth and proliferation of harmful microorganisms. Synonyms: 5S-GlcNAc. CAS No. 77583-99-4. Molecular formula: C8H15NO5S. Mole weight: 237.27. | |
| 2-Acetamido-2-deoxy-6-O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-3-O-(b-D-galactopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-6-O-(2-acetamido-2-deoxy-b-D-galactopyranosyl)-3-O-(b-D-galactopyranosyl)-D-glucopyranose is a compound extensively exploited in the biomedical domain, exhibiting potential for combatting diverse malignancies. In the research of cancer, this remarkable entity manifests itself as an effective disruptor of cell proliferation and an inducer of programmed cell death. Synonyms: Gal-b-1,3-(GlcNAc-b-1,6-)GalNAc. | |
| 2-Acetamido-2-deoxy-6-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose | 2-Acetamido-2-deoxy-6-O-(2-acetamido-2-deoxy-b-D-glucopyranosyl)-D-galactopyranose - an extensively employed compound in the realm of biomedicine, serves manifold objectives. Notably, it manifests remarkable significance in drug exploration, targeting bacterial and viral ailments. Furthermore, it assumes a fundamental position in comprehending the intricate molecular interplays governing glycoprotein genesis and modification. Synonyms: 2-(Acetylamino)-6-O-[2-(acetylamino)-2-deoxy-b-D-glucopyranosyl]-2-deoxy-a-D-galactose GlcNAc1b-6GalNAc. CAS No. 452316-31-3. Molecular formula: C16H28N2O11. Mole weight: 424.40. | |
| 2-Acetamido-2-deoxy-6-O-(a-L-fucopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-6-O-(a-L-fucopyranosyl)-D-glucopyranose is a fundamental bioactive compound found in biomedicine. It undertakes an indispensable function in the research of diverse afflictions, encompassing malignant neoplasms and infirmities characterized by inflammation. Remarkably, it showcases auspicious prospects as an agent impeding the proliferation of tumors. Synonyms: Fuc-a-1,6-GlcNAc. CAS No. 33639-80-4. Molecular formula: C14H25NO10. Mole weight: 367.35. | |
| 2-Acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-6-O-(b-D-galactopyranosyl)-D-glucopyranose, a carbohydrate molecule, finds widespread use in biomedical studies as a valuable biomarker to investigate physiological conditions involving colon cancer and Crohn's disease. Its versatility extends further to positively impacting drug discovery and therapeutic development for these ailments. Synonyms: Galβ1-6GlcNAc; β1-6 Galactosyl-N-acetyl glucosamine; Gal-b-1,6-GlcNAc; N-Acetylallolactosamine; beta-D-Galp-(1->6)-D-GlcNAcp; 6-O-beta-D-Galactopyranosyl-2-(acetylamino)-2-deoxy-D-glucopyranose. Grades: ≥90%. CAS No. 50787-10-5. Molecular formula: C14H25NO11. Mole weight: 383.35. | |
| 2-Acetamido-2-deoxy-6-O-(beta-D-galactopyranosyl)-D-glucopyranose | 2-Acetamido-2-deoxy-6-O-(beta-D-galactopyranosyl)-D-glucopyranose. Uses: Designed for use in research and industrial production. Additional or Alternative Names: N-Acetylallolactosamine, 50787-10-5, AC1L1BNX, A0724_SIGMA, A7916_SIGMA, 72142-81-5, |A-galactosyl-(1-6)-N-acetylglucosamine, beta-galactosyl-(1-6)-N-acetylglucosamine, 2-(acetylamino)-2-deoxy-6-O-hexopyranosylhexose, |A-D-Gal-(1 inverted exclamation marku6)-D-GlcNAc, 2-(acetylamino)-2-deoxy-6-O-beta-D-galactopyranosyl-D-galactose, 2-Acetamido-2-deoxy-6-O-(|A-D-galactopyranosyl)-D-glucopyranose, 2-Acetamido-2-deoxy-6-O-(beta-D-galactopyranosyl)-D-glucopyranose, N-[3,4,5-trihydroxy-1-oxo-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide. Product Category: Heterocyclic Organic Compound. CAS No. 50787-10-5. Molecular formula: C14H25NO11. Mole weight: 383.35. Purity: 0.96. IUPACName: N-[3,4,5-trihydroxy-1-oxo-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexan-2-yl]acetamide. Canonical SMILES: CC(=O)NC(C=O)C(C(C(COC1C(C(C(C(O1)CO)O)O)O)O)O)O. Density: 1.58g/cm³. Product ID: ACM50787105. Alfa Chemistry ISO 9001:2015 Certified. Categories: Gal(b1-6)GlcNAc. | |
| 2-Acetamido-2-deoxy-b-D-glucopyranosyl L-asparagine | 2-Acetamido-2-deoxy-b-D-glucopyranosyl L-asparagine is a glycosylation inhibitor and can effectively hamper the biosynthesis of N-linked glycopeptides. Synonyms: b-D-GlcNAc-(1?N)-Asn; 2-Acetamido-1-β-(L-aspartamido)-1,2-dideoxy-D-glucose. Grades: ≥ 99% (TLC). CAS No. 2776-93-4. Molecular formula: C12H21N3O8. Mole weight: 335.31. | |
Our database is helping our users find suppliers everyday.
